Epix to raise $30 million

Contrast agent developer Epix Medical has signed an agreement with investment banking firm Robertson Stephens, which will serve as a placement agent for newly issued Epix shares. Robertson Stephens has received commitments from a group of existing and new Epix investors for 2.6 million shares at a price of $12.50 a share, resulting in net proceeds of approximately $30.2 million, according to Cambridge, MA-based Epix.

By AuntMinnie.com staff writers
January 16, 2002

Related Reading

Epix revenues climb in Q3, October 19, 2001

Epix, Bracco ink licensing deal, September 25, 2001

Wirth joins Epix Medical board, August 30, 2001

Epix net loss grows in Q2, July 27, 2001

Epix trims net loss, April 27, 2001

Copyright © 2002 AuntMinnie.com

Page 1 of 3590
Next Page